· 3hNJBIZ
Drug compounders sue FDA over Novo Nordisk’s Ozempic, Wegovy
 · 1dFiercePharma
Compounders sue FDA again over declaring end of shortage for Novo's semaglutide
Novo’s Weight Loss Drugs Removed from FDA Shortage List
FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the end to the booming market for cheaper versions made by pharmacies.
Why Novo Nordisk Stock Popped on Friday
Novo Nordisk ( NVO 5.29%) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ) that's also probably bad news for Hims & Hers Health ( HIMS -17.80%).